By focusing on general molecular mechanisms of antiviral drugs rather than therapies for individual viruses, this ready reference provides the critical knowledge needed to develop entirely novel therapeutics and to target new viruses.
It begins with a general discussion of antiviral strategies, followed by a broad survey of known viral targets, such as reverse transcriptases, proteases, neuraminidases, RNA polymerases, helicases and primases, as well as their known inhibitors. The final section contains several cases studies of recent successful antiviral drug development.
Edited by Erik de Clercq, the world authority on small molecule antiviral drugs, who has developed more new antivirals than anyone else.
It begins with a general discussion of antiviral strategies, followed by a broad survey of known viral targets, such as reverse transcriptases, proteases, neuraminidases, RNA polymerases, helicases and primases, as well as their known inhibitors. The final section contains several cases studies of recent successful antiviral drug development.
Edited by Erik de Clercq, the world authority on small molecule antiviral drugs, who has developed more new antivirals than anyone else.
Zahle einfach mit Karte, Klarna, Apple Pay oder Google Pay. Nicht zufrieden? Du hast immer ein 14-tägiges Widerrufsrecht. Lies mehr in unseren AGB. Hast du Fragen, schreib uns eine E-Mail an hello@memmo.org.
Memmo macht das Lernen einfacher – wo auch immer du bist. Bei uns findest du deine Kursbücher und smarte Lerntools an einem Ort: Zusammenfassungen, Quizzes, Podcasts und Lernkarten. Und Ted, dein Lernbuddy, beantwortet alles, was du wissen möchtest. Über 50.000 Studierende lernen bereits hier – gemacht, damit du schneller lernst und weniger Stress hast.